1. Home
  2. NTIC vs ELTX Comparison

NTIC vs ELTX Comparison

Compare NTIC & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

HOLD

Current Price

$7.75

Market Cap

75.1M

Sector

Industrials

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$1.86

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTIC
ELTX
Founded
1970
2011
Country
United States
United States
Employees
94
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.1M
63.3M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
NTIC
ELTX
Price
$7.75
$1.86
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$18.00
AVG Volume (30 Days)
11.0K
339.6K
Earning Date
04-09-2026
05-12-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
39.29
EPS
N/A
N/A
Revenue
$84,234,474.00
$2,301,000.00
Revenue This Year
$12.49
N/A
Revenue Next Year
$7.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.35
$1.71
52 Week High
$10.03
$16.00

Technical Indicators

Market Signals
Indicator
NTIC
ELTX
Relative Strength Index (RSI) 49.91 N/A
Support Level $7.88 N/A
Resistance Level $8.09 N/A
Average True Range (ATR) 0.19 0.00
MACD 0.00 0.00
Stochastic Oscillator 66.67 0.00

Price Performance

Historical Comparison
NTIC
ELTX

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: